An observational study on the incidence of tuberculosis among a cohort of HIV infected adults in a setting with low prevalence of tuberculosis

References

• Horsburgh CR, Jr. Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med. 2004;350(20):2060–2067.10.1056/NEJMsa031667
   PubMed Web of Science ®Google Scholar
• WHO, UNAIDS. Policy Statement on Preventive Therapy against Tuberculosis in People Living with HIV. Geneva: WHO; 1998.
   Google Scholar
• Akolo C, Adetifa I, Shepperd S, Volmink J. Treatment of latent tuberculosis in HIV infected persons. Cochrane Database Syst Rev. 2010;1:CD000171.
   PubMed Web of Science ®Google Scholar
• Girardi E, Sabin CA, d’Arminio MA, et al. Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America. Clin Infect Dis. 2005;41:1772–1782.
   PubMed Web of Science ®Google Scholar
• British HIV Association. British HIV Association guidelines for the treatment of TB/HIV coinfection 2011. HIV Med. 2011;12:517–524.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Guidelines for Intensified Tuberculosis Case-finding and Isoniazid Preventive Therapy for People Living with HIV in Resource Constrained Settings. Geneva: Department of HIV/AIDS, Stop TB Department, World Health Organization; 2010.
   Google Scholar
• Boehme CC, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med. 2010;363:1005–1015.10.1056/NEJMoa0907847
   PubMed Web of Science ®Google Scholar
• TEMPRANO ANRS 12136 Study Group. A trial of early antiretrovirals and isoniazid preventive therapy in Africa. N Engl J Med. 2015;373:808–822.10.1056/NEJMoa1507198.
   PubMed Web of Science ®Google Scholar
• Elzi L, Schlegel M, Weber R, et al. Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission. Clin Infect Dis. 2007;44:94–102.10.1086/cid.2007.44.issue-1
   PubMed Web of Science ®Google Scholar
• Yirdaw KD, Jerene D, Gashu Z, et al. Beneficial effect of isoniazid preventive therapy and antiretroviral therapy on the incidence of tuberculosis in people living with HIV in Ethiopia. PLoSOne. 2014;9(8):e104557. 10.1371/journal.pone.0104557.
   PubMed Web of Science ®Google Scholar
• Hermans SM, Kiragga AN, Schaefer P, Kambugu A, Hoepelman AIM, Manabe YC. Incident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban hiv clinic in sub-saharan Africa. PLoSOne. 2010;5(5):e10527.10.1371/journal.pone.0010527
   PubMed Web of Science ®Google Scholar
• Gupta A, Wood R, Kaplan R, Bekker LG, Lawn SD. Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community. PLoSOne. 2012;7(3):e34156.10.1371/journal.pone.0034156
   PubMed Web of Science ®Google Scholar
• Dean AG, Sullivan KM, Soe MM. OpenEi: Open source epidemiologic statistics for public health, version 3.03a. www.OpenEpi.com, updated 04/05/2015, Accessed November 11, 2015.
   Google Scholar
• Balcha TT, Sturegård E, Winqvist N, et al. Intensified tuberculosis case-finding in HIV-positive adults managed at Ethiopian health centers: diagnostic yield of xpert MTB/RIF compared with smear microscopy and liquid culture. PLoSOne. 2014;9(1):e85478.10.1371/journal.pone.0085478
   PubMed Web of Science ®Google Scholar
• Shea KM, Kammerer JS, Winston CA, Navin TR, Horsburgh CR, Jr. Estimated rate of reactivation of latent tuberculosis infection in the United States, overall and by population subgroup. Am J Epidemiol. 2014;179(2):216–225.10.1093/aje/kwt246
   PubMed Web of Science ®Google Scholar
• Houben RM, Crampin AC, Ndhlovu R, et al. Human immunodeficiency virus associated tuberculosis more often due to recent infection than reactivation of latent infection. Int J Tuberc Lung Dis. 2011;15(1):24–31.
   PubMed Web of Science ®Google Scholar
• Li J, Munsiff SS, Tarantino T, Dorsinville M. Adherence to treatment of latent tuberculosis infection in a clinical population in New York City. Int J Infect Dis. 2010;14(4):e292–e297. 10.1016/j.ijid.2009.05.007.
   PubMed Web of Science ®Google Scholar
• van Griensven J, Choun K, Chim B, Thai S, Lorent N, Lynen L. Implementation of isoniazid preventive therapy in an HIV clinic in Cambodia: high rates of discontinuation when combined with antiretroviral therapy. Trop Med Int Health. 2015;20(12):1823–1831. 10.1111/tmi.12609.
   PubMed Web of Science ®Google Scholar
• Oni T, Tsekela R, Kwaza B, et al. A recent HIV diagnosis is associated with non-completion of isoniazid preventive therapy in an HIV-infected cohort in Cape Town. PLoSOne. 2012;7(12):e52489. 10.1371/journal.pone.0052489.
   PubMed Web of Science ®Google Scholar
• Matteelli A, Casalini C, Raviglione MC, et al. Supervised preventive therapy for latent tuberculosis infection in illegal immigrants in Italy. Am J Respir Crit Care Med. 2000;162(5):1653–1655.10.1164/ajrccm.162.5.9912062
   PubMed Web of Science ®Google Scholar
• van Halsema CL, Fielding KL, Chihota VN, Russell EC, Lewis JJ, Churchyard GJ, et al. Tuberculosis outcomes and drug susceptibility in individuals exposed to isoniazid preventive therapy in a high HIV prevalence setting. AIDS. 2010;24(7):1051–1055.10.1097/QAD.0b013e32833849df
   PubMed Web of Science ®Google Scholar
• Getahun H, Kittikraisak W, Heilig CM, et al. Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies. PLoS Med. 2011;8(1):e1000391.10.1371/journal.pmed.1000391
   PubMed Web of Science ®Google Scholar
• Rangaka MX, Wilkinson RJ, Glynn JR, et al. Effect of antiretroviral therapy on the diagnostic accuracy of symptom screening for intensified tuberculosis case finding in a South African HIV clinic. Clin Infect Dis. 2012;55(12):1698–1706. 10.1093/cid/cis775.
   PubMed Web of Science ®Google Scholar
• Walls T, Shingadia D. The epidemiology of tuberculosis in Europe. Arch Dis Child. 2007;92:726–729.10.1136/adc.2006.102889
   PubMed Web of Science ®Google Scholar
• The INSIGHT START Study Group. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med. 2015;373:795–807.
   PubMed Web of Science ®Google Scholar